{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T03:46:25Z","timestamp":1794023185120,"version":"4.8.0"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T00:00:00Z","timestamp":1752192000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T00:00:00Z","timestamp":1752192000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R21AI139386"],"award-info":[{"award-number":["R21AI139386"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI168088"],"award-info":[{"award-number":["R01AI168088"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007491","name":"Donald E. and Delia B. Baxter Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R35GM148351"],"award-info":[{"award-number":["R35GM148351"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006445","name":"Center for Hierarchical Manufacturing, National Science Foundation","doi-asserted-by":"publisher","award":["2117338"],"award-info":[{"award-number":["2117338"]}],"id":[{"id":"10.13039\/100006445","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-61703-3","type":"journal-article","created":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T18:54:39Z","timestamp":1752260079000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Trehalose catalytic shift inherently enhances phenotypic heterogeneity and multidrug resistance in Mycobacterium tuberculosis"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8317-437X","authenticated-orcid":false,"given":"Jae Jin","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel H.","family":"Swanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun-Kyung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Dihardjo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gi Yong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sree","family":"Gelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9697-2677","authenticated-orcid":false,"given":"Hoon Je","family":"Seong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily R. M.","family":"Bravo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary E.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Van Nieuwenhze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1451-2838","authenticated-orcid":false,"given":"Abhyudai","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Seok","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seokyong","family":"Eum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SangNae","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin M.","family":"Swarts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8774-6400","authenticated-orcid":false,"given":"Hyungjin","family":"Eoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,11]]},"reference":[{"key":"61703_CR1","unstructured":"WHO. Global Tuberculosis Report (WHO, 2024)."},{"key":"61703_CR2","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.chom.2009.02.004","volume":"5","author":"C Nathan","year":"2009","unstructured":"Nathan, C. Taming tuberculosis: a challenge for science and society. Cell Host Microbe 5, 220\u2013224 (2009).","journal-title":"Cell Host Microbe"},{"key":"61703_CR3","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nm.3470","volume":"20","author":"C Nathan","year":"2014","unstructured":"Nathan, C. Drug-resistant tuberculosis: a new shot on goal. Nat. Med. 20, 121\u2013123 (2014).","journal-title":"Nat. Med."},{"key":"61703_CR4","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/microbiolspec.TBTB2-0031-2016","volume":"5","author":"B Gold","year":"2017","unstructured":"Gold, B. & Nathan, C. Targeting phenotypically tolerant Mycobacterium tuberculosis. Microbiol. Spectr. 5, 10\u20131128 (2017).","journal-title":"Microbiol. Spectr."},{"key":"61703_CR5","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/978-1-4939-2450-9_18","volume":"1285","author":"B Gold","year":"2015","unstructured":"Gold, B., Warrier, T. & Nathan, C. A multi-stress model for high-throughput screening against non-replicating Mycobacterium tuberculosis. Methods Mol. Biol. 1285, 293\u2013315 (2015).","journal-title":"Methods Mol. Biol."},{"key":"61703_CR6","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.tim.2011.03.008","volume":"19","author":"KY Rhee","year":"2011","unstructured":"Rhee, K. Y. et al. Central carbon metabolism in Mycobacterium tuberculosis: an unexpected frontier. Trends Microbiol. 19, 307\u2013314 (2011).","journal-title":"Trends Microbiol."},{"key":"61703_CR7","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abh2037","volume":"7","author":"SM Schrader","year":"2021","unstructured":"Schrader, S. M. et al. Multiform antimicrobial resistance from a metabolic mutation. Sci. Adv. 7, eabh2037 (2021).","journal-title":"Sci. Adv."},{"key":"61703_CR8","doi-asserted-by":"publisher","first-page":"958240","DOI":"10.3389\/fcimb.2022.958240","volume":"12","author":"H Eoh","year":"2022","unstructured":"Eoh, H., Liu, R., Lim, J., Lee, J. J. & Sell, P. Central carbon metabolism remodeling as a mechanism to develop drug tolerance and drug resistance in Mycobacterium tuberculosis. Front. Cell. Infect. Microbiol. 12, 958240 (2022).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"61703_CR9","first-page":"107","volume":"322","author":"K Lewis","year":"2008","unstructured":"Lewis, K. Multidrug tolerance of biofilms and persister cells. Curr. Top. Microbiol. Immunol. 322, 107\u2013131 (2008).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"61703_CR10","first-page":"257","volume":"30","author":"W McDermott","year":"1958","unstructured":"McDermott, W. Microbial persistence. Yale J. Biol. Med. 30, 257\u2013291 (1958).","journal-title":"Yale J. Biol. Med."},{"key":"61703_CR11","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1128\/AAC.06288-11","volume":"56","author":"Y Zhang","year":"2012","unstructured":"Zhang, Y., Yew, W. W. & Barer, M. R. Targeting persisters for tuberculosis control. Antimicrob. Agents Chemother. 56, 2223\u20132230 (2012).","journal-title":"Antimicrob. Agents Chemother."},{"key":"61703_CR12","doi-asserted-by":"publisher","first-page":"e51034","DOI":"10.15252\/embr.202051034","volume":"21","author":"M Huemer","year":"2020","unstructured":"Huemer, M., Mairpady Shambat, S., Brugger, S. D. & Zinkernagel, A. S. Antibiotic resistance and persistence-implications for human health and treatment perspectives. EMBO Rep. 21, e51034 (2020).","journal-title":"EMBO Rep."},{"key":"61703_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10975-7","volume":"10","author":"JJ Lee","year":"2019","unstructured":"Lee, J. J. et al. Transient drug-tolerance and permanent drug-resistance rely on the trehalose-catalytic shift in Mycobacterium tuberculosis. Nat. Commun. 10, 2928 (2019).","journal-title":"Nat. Commun."},{"key":"61703_CR14","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1093\/femsre\/fux001","volume":"41","author":"B Van den Bergh","year":"2017","unstructured":"Van den Bergh, B., Fauvart, M. & Michiels, J. Formation, physiology, ecology, evolution and clinical importance of bacterial persisters. FEMS Microbiol. Rev. 41, 219\u2013251 (2017).","journal-title":"FEMS Microbiol. Rev."},{"key":"61703_CR15","doi-asserted-by":"publisher","first-page":"4495","DOI":"10.1073\/pnas.1704376114","volume":"114","author":"C Vilcheze","year":"2017","unstructured":"Vilcheze, C. et al. Enhanced respiration prevents drug tolerance and drug resistance in Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 114, 4495\u20134500 (2017).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"61703_CR16","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.3389\/fmicb.2020.01785","volume":"11","author":"Z Podlesek","year":"2020","unstructured":"Podlesek, Z. & Zgur Bertok, D. The DNA damage inducible SOS response is a key player in the generation of bacterial persister cells and population-wide tolerance. Front. Microbiol. 11, 1785 (2020).","journal-title":"Front. Microbiol."},{"key":"61703_CR17","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.02144-17","volume":"9","author":"RC Molina-Quiroz","year":"2018","unstructured":"Molina-Quiroz, R. C. et al. Cyclic AMP regulates bacterial persistence through repression of the oxidative stress response and SOS-dependent DNA repair in uropathogenic Escherichia coli. MBio 9, e02144-17 (2018).","journal-title":"MBio"},{"key":"61703_CR18","doi-asserted-by":"publisher","first-page":"956607","DOI":"10.3389\/fcimb.2022.956607","volume":"12","author":"T Parbhoo","year":"2022","unstructured":"Parbhoo, T., Mouton, J. M. & Sampson, S. L. Phenotypic adaptation of Mycobacterium tuberculosis to host-associated stressors that induce persister formation. Front. Cell Infect. Microbiol. 12, 956607 (2022).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"61703_CR19","doi-asserted-by":"publisher","first-page":"5577","DOI":"10.1128\/AEM.05068-11","volume":"77","author":"X Wang","year":"2011","unstructured":"Wang, X. & Wood, T. K. Toxin-antitoxin systems influence biofilm and persister cell formation and the general stress response. Appl. Environ. Microbiol. 77, 5577\u20135583 (2011).","journal-title":"Appl. Environ. Microbiol."},{"key":"61703_CR20","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1146\/annurev-micro-092611-150159","volume":"66","author":"K Gerdes","year":"2012","unstructured":"Gerdes, K. & Maisonneuve, E. Bacterial persistence and toxin-antitoxin loci. Annu. Rev. Microbiol. 66, 103\u2013123 (2012).","journal-title":"Annu. Rev. Microbiol."},{"key":"61703_CR21","doi-asserted-by":"publisher","first-page":"6554","DOI":"10.1073\/pnas.1219375110","volume":"110","author":"H Eoh","year":"2013","unstructured":"Eoh, H. & Rhee, K. Y. Multifunctional essentiality of succinate metabolism in adaptation to hypoxia in Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 110, 6554\u20136559 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"61703_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/nmicrobiol.2017.84","volume":"2","author":"H Eoh","year":"2017","unstructured":"Eoh, H. et al. Metabolic anticipation in Mycobacterium tuberculosis. Nat. Microbiol. 2, 17084 (2017).","journal-title":"Nat. Microbiol."},{"key":"61703_CR23","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2105800118","volume":"118","author":"J Lim","year":"2021","unstructured":"Lim, J. et al. Phosphoenolpyruvate depletion mediates both growth arrest and drug tolerance of Mycobacterium tuberculosis in hypoxia. Proc. Natl. Acad. Sci. USA 118, e2105800118 (2021).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"61703_CR24","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.03559-21","volume":"13","author":"CG Quinonez","year":"2022","unstructured":"Quinonez, C. G. et al. The role of fatty acid metabolism in drug tolerance of Mycobacterium tuberculosis. MBio 13, e0355921 (2022).","journal-title":"MBio"},{"key":"61703_CR25","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1016\/j.chembiol.2010.08.009","volume":"17","author":"LP de Carvalho","year":"2010","unstructured":"de Carvalho, L. P. et al. Metabolomics of Mycobacterium tuberculosis reveals compartmentalized co-catabolism of carbon substrates. Chem. Biol. 17, 1122\u20131131 (2010).","journal-title":"Chem. Biol."},{"key":"61703_CR26","doi-asserted-by":"publisher","first-page":"123","DOI":"10.15698\/mic2022.05.777","volume":"9","author":"CG Quinonez","year":"2022","unstructured":"Quinonez, C. G. et al. Fatty acid metabolism of Mycobacterium tuberculosis: a double-edged sword. Micro Cell 9, 123\u2013125 (2022).","journal-title":"Micro Cell"},{"key":"61703_CR27","doi-asserted-by":"publisher","DOI":"10.15252\/msb.202110280","volume":"17","author":"K Borah","year":"2021","unstructured":"Borah, K. et al. Metabolic fluxes for nutritional flexibility of Mycobacterium tuberculosis. Mol. Syst. Biol. 17, e10280 (2021).","journal-title":"Mol. Syst. Biol."},{"key":"61703_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19959-4","volume":"11","author":"JS Mackenzie","year":"2020","unstructured":"Mackenzie, J. S. et al. Bedaquiline reprograms central metabolism to reveal glycolytic vulnerability in Mycobacterium tuberculosis. Nat. Commun. 11, 6092 (2020).","journal-title":"Nat. Commun."},{"key":"61703_CR29","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1126\/science.1228980","volume":"339","author":"S Chakraborty","year":"2013","unstructured":"Chakraborty, S. et al. Para-aminosalicylic acid acts as an alternative substrate of folate metabolism in Mycobacterium tuberculosis. Science 339, 88\u201391 (2013).","journal-title":"Science"},{"key":"61703_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5306","volume":"5","author":"M Nandakumar","year":"2014","unstructured":"Nandakumar, M., Nathan, C. & Rhee, K. Y. Isocitrate lyase mediates broad antibiotic tolerance in Mycobacterium tuberculosis. Nat. Commun. 5, 4306 (2014).","journal-title":"Nat. Commun."},{"key":"61703_CR31","doi-asserted-by":"publisher","first-page":"19646","DOI":"10.1073\/pnas.1907946116","volume":"116","author":"Z Wang","year":"2019","unstructured":"Wang, Z. et al. Mode-of-action profiling reveals glutamine synthetase as a collateral metabolic vulnerability of M. tuberculosis to bedaquiline. Proc. Natl. Acad. Sci. USA 116, 19646\u201319651 (2019).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"61703_CR32","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.mib.2014.09.003","volume":"21","author":"NM Vega","year":"2014","unstructured":"Vega, N. M. & Gore, J. Collective antibiotic resistance: mechanisms and implications. Curr. Opin. Microbiol 21, 28\u201334 (2014).","journal-title":"Curr. Opin. Microbiol"},{"key":"61703_CR33","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.molcel.2019.09.028","volume":"76","author":"L Dewachter","year":"2019","unstructured":"Dewachter, L., Fauvart, M. & Michiels, J. Bacterial heterogeneity and antibiotic survival: understanding and combatting persistence and heteroresistance. Mol. Cell 76, 255\u2013267 (2019).","journal-title":"Mol. Cell"},{"key":"61703_CR34","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jgar.2016.11.010","volume":"8","author":"MA Arepyeva","year":"2017","unstructured":"Arepyeva, M. A. et al. A mathematical model for predicting the development of bacterial resistance based on the relationship between the level of antimicrobial resistance and the volume of antibiotic consumption. J. Glob. Antimicrob. Resist. 8, 148\u2013156 (2017).","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"61703_CR35","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1126\/science.aar7981","volume":"362","author":"I El Meouche","year":"2018","unstructured":"El Meouche, I. & Dunlop, M. J. Heterogeneity in efflux pump expression predisposes antibiotic-resistant cells to mutation. Science 362, 686\u2013690 (2018).","journal-title":"Science"},{"key":"61703_CR36","doi-asserted-by":"publisher","first-page":"e00500","DOI":"10.1128\/mBio.00500-17","volume":"8","author":"J Olivares Pacheco","year":"2017","unstructured":"Olivares Pacheco, J., Alvarez-Ortega, C., Alcalde Rico, M. & Martinez, J. L.Metabolic compensation of fitness costs is a general outcome for antibiotic-resistant pseudomonas aeruginosa mutants overexpressing efflux pumps. MBio 8, e00500\u2013e00517 (2017).","journal-title":"MBio"},{"key":"61703_CR37","doi-asserted-by":"publisher","first-page":"585175","DOI":"10.3389\/fmicb.2020.585175","volume":"11","author":"SA Revitt-Mills","year":"2020","unstructured":"Revitt-Mills, S. A. & Robinson, A. Antibiotic-induced mutagenesis: Under the Microscope. Front. Microbiol. 11, 585175 (2020).","journal-title":"Front. Microbiol."},{"key":"61703_CR38","doi-asserted-by":"crossref","unstructured":"Kalscheuer, R. & Koliwer-Brandl, H. Genetics of mycobacterial trehalose metabolism. Microbiol. Spectr. 2 (2014).","DOI":"10.1128\/microbiolspec.MGM2-0002-2013"},{"key":"61703_CR39","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1021\/acsinfecdis.4c00138","volume":"10","author":"K Kalera","year":"2024","unstructured":"Kalera, K. et al. Targeting Mycobacterium tuberculosis Persistence through inhibition of the trehalose catalytic shift. ACS Infect. Dis. 10, 1391\u20131404 (2024).","journal-title":"ACS Infect. Dis."},{"key":"61703_CR40","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/s41564-022-01130-y","volume":"7","author":"S Li","year":"2022","unstructured":"Li, S. et al. CRISPRi chemical genetics and comparative genomics identify genes mediating drug potency in Mycobacterium tuberculosis. Nat. Microbiol 7, 766\u2013779 (2022).","journal-title":"Nat. Microbiol"},{"key":"61703_CR41","doi-asserted-by":"publisher","first-page":"e1007975","DOI":"10.1371\/journal.ppat.1007975","volume":"15","author":"J Rock","year":"2019","unstructured":"Rock, J. Tuberculosis drug discovery in the CRISPR era. PLOS Pathog. 15, e1007975 (2019).","journal-title":"PLOS Pathog."},{"key":"61703_CR42","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.mib.2009.06.018","volume":"12","author":"DJ Dwyer","year":"2009","unstructured":"Dwyer, D. J., Kohanski, M. A. & Collins, J. J. Role of reactive oxygen species in antibiotic action and resistance. Curr. Opin. Microbiol. 12, 482\u2013489 (2009).","journal-title":"Curr. Opin. Microbiol."},{"key":"61703_CR43","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.molcel.2010.01.027","volume":"37","author":"BB Kaufmann","year":"2010","unstructured":"Kaufmann, B. B. & Hung, D. T. The fast track to multidrug resistance. Mol. Cell 37, 297\u2013298 (2010).","journal-title":"Mol. Cell"},{"key":"61703_CR44","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.mrfmmm.2015.08.005","volume":"781","author":"Q Zheng","year":"2015","unstructured":"Zheng, Q. A new practical guide to the Luria-Delbr\u00fcck protocol. Mutat. Res. 781, 7\u201313 (2015).","journal-title":"Mutat. Res."},{"key":"61703_CR45","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1038\/ng.2656","volume":"45","author":"CB Ford","year":"2013","unstructured":"Ford, C. B. et al. Mycobacterium tuberculosis mutation rate estimates from different lineages predict substantial differences in the emergence of drug-resistant tuberculosis. Nat. Genet. 45, 784\u2013790 (2013).","journal-title":"Nat. Genet."},{"key":"61703_CR46","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/ja.2014.107","volume":"67","author":"BP Goldstein","year":"2014","unstructured":"Goldstein, B. P. Resistance to rifampicin: a review. J. Antibiot.67, 625\u2013630 (2014).","journal-title":"J. Antibiot."},{"key":"61703_CR47","doi-asserted-by":"publisher","first-page":"4119","DOI":"10.2147\/IDR.S333433","volume":"14","author":"MC Li","year":"2021","unstructured":"Li, M. C. et al. rpoB mutations and effects on rifampin resistance in mycobacterium tuberculosis. Infect. Drug Resist. 14, 4119\u20134128 (2021).","journal-title":"Infect. Drug Resist."},{"key":"61703_CR48","doi-asserted-by":"publisher","first-page":"e01599","DOI":"10.1128\/JCM.01599-17","volume":"56","author":"P Miotto","year":"2018","unstructured":"Miotto, P., Cabibbe, A. M., Borroni, E., Degano, M. & Cirillo, D. M. Role of disputed mutations in the rpob gene in interpretation of automated liquid mgit culture results for rifampin susceptibility testing of mycobacterium tuberculosis. J. Clin. Microbiol. 56, e01599\u201317 (2018).","journal-title":"J. Clin. Microbiol."},{"key":"61703_CR49","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.mib.2006.12.007","volume":"10","author":"N Dhar","year":"2007","unstructured":"Dhar, N. & McKinney, J. D. Microbial phenotypic heterogeneity and antibiotic tolerance. Curr. Opin. Microbiol. 10, 30\u201338 (2007).","journal-title":"Curr. Opin. Microbiol."},{"key":"61703_CR50","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1073\/pnas.1316084111","volume":"111","author":"MA Sanchez-Romero","year":"2014","unstructured":"Sanchez-Romero, M. A. & Casadesus, J. Contribution of phenotypic heterogeneity to adaptive antibiotic resistance. Proc. Natl. Acad. Sci. USA 111, 355\u2013360 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"61703_CR51","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/nrmicro1460","volume":"4","author":"SV Avery","year":"2006","unstructured":"Avery, S. V. Microbial cell individuality and the underlying sources of heterogeneity. Nat. Rev. Microbiol. 4, 577\u2013587 (2006).","journal-title":"Nat. Rev. Microbiol."},{"key":"61703_CR52","doi-asserted-by":"publisher","first-page":"19665","DOI":"10.1073\/pnas.1907631116","volume":"116","author":"H Safi","year":"2019","unstructured":"Safi, H. et al. Phase variation in Mycobacterium tuberculosis glpK produces transiently heritable drug tolerance. Proc. Natl. Acad. Sci. USA 116, 19665\u201319674 (2019).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"61703_CR53","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202213563","volume":"62","author":"N Banahene","year":"2023","unstructured":"Banahene, N. et al. A far-red molecular rotor fluorogenic trehalose probe for live mycobacteria detection and drug-susceptibility testing. Angew. Chem. Int. Ed. Engl. 62, e202213563 (2023).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"61703_CR54","doi-asserted-by":"publisher","first-page":"25041","DOI":"10.1074\/jbc.M114.581579","volume":"289","author":"KM Backus","year":"2014","unstructured":"Backus, K. M. et al. The three Mycobacterium tuberculosis antigen 85 isoforms have unique substrates and activities determined by non-active site regions. J. Biol. Chem. 289, 25041\u201325053 (2014).","journal-title":"J. Biol. Chem."},{"key":"61703_CR55","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1128\/CMR.18.1.81-101.2005","volume":"18","author":"K Takayama","year":"2005","unstructured":"Takayama, K., Wang, C. & Besra, G. S. Pathway to synthesis and processing of mycolic acids in Mycobacterium tuberculosis. Clin. Microbiol. Rev. 18, 81\u2013101 (2005).","journal-title":"Clin. Microbiol. Rev."},{"key":"61703_CR56","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1128\/AAC.05708-11","volume":"56","author":"K Tahlan","year":"2012","unstructured":"Tahlan, K. et al. SQ109 targets MmpL3, a membrane transporter of trehalose monomycolate involved in mycolic acid donation to the cell wall core of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 56, 1797\u20131809 (2012).","journal-title":"Antimicrob. Agents Chemother."},{"key":"61703_CR57","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/nature22794","volume":"546","author":"SM Shaffer","year":"2017","unstructured":"Shaffer, S. M. et al. Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance. Nature 546, 431\u2013435 (2017).","journal-title":"Nature"},{"key":"61703_CR58","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1158\/2159-8290.CD-20-1265","volume":"12","author":"CA Chang","year":"2022","unstructured":"Chang, C. A. et al. Ontogeny and vulnerabilities of drug-tolerant persisters in HER2+ breast cancer. Cancer Discov. 12, 1022\u20131045 (2022).","journal-title":"Cancer Discov."},{"key":"61703_CR59","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.cell.2020.07.003","volume":"182","author":"SM Shaffer","year":"2020","unstructured":"Shaffer, S. M. et al. Memory sequencing reveals heritable single-cell gene expression programs associated with distinct cellular behaviors. Cell 182, 947\u2013959.e917 (2020).","journal-title":"Cell"},{"key":"61703_CR60","doi-asserted-by":"publisher","first-page":"1050516","DOI":"10.3389\/fmicb.2022.1050516","volume":"13","author":"A Singh","year":"2022","unstructured":"Singh, A. & Saint-Antoine, M. Probing transient memory of cellular states using single-cell lineages. Front. Microbiol. 13, 1050516 (2022).","journal-title":"Front. Microbiol."},{"key":"61703_CR61","doi-asserted-by":"publisher","first-page":"e0121923","DOI":"10.1128\/spectrum.01219-23","volume":"11","author":"T Hossain","year":"2023","unstructured":"Hossain, T., Singh, A. & Butzin, N. C. Escherichia coli cells are primed for survival before lethal antibiotic stress. Microbiol. Spectr. 11, e0121923 (2023).","journal-title":"Microbiol. Spectr."},{"key":"61703_CR62","doi-asserted-by":"publisher","unstructured":"Saint-Antoine, M. G. R. S. A. A fluctuation-based approach to infer kinetics and topology of cell-state switching. bioRxiv https:\/\/doi.org\/10.1101\/2022.03.30.486492 (2022).","DOI":"10.1101\/2022.03.30.486492"},{"key":"61703_CR63","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1128\/MMBR.00016-10","volume":"74","author":"J Davies","year":"2010","unstructured":"Davies, J. & Davies, D. Origins and evolution of antibiotic resistance. Microbiol. Mol. Biol. Rev. 74, 417\u2013433 (2010).","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"61703_CR64","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1126\/science.aaj2191","volume":"355","author":"I Levin-Reisman","year":"2017","unstructured":"Levin-Reisman, I. et al. Antibiotic tolerance facilitates the evolution of resistance. Science 355, 826\u2013830 (2017).","journal-title":"Science"},{"key":"61703_CR65","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1126\/science.aam7926","volume":"355","author":"K Lewis","year":"2017","unstructured":"Lewis, K. & Shan, Y. Why tolerance invites resistance. Science 355, 796 (2017).","journal-title":"Science"},{"key":"61703_CR66","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/nature12212","volume":"499","author":"SR Modi","year":"2013","unstructured":"Modi, S. R., Lee, H. H., Spina, C. S. & Collins, J. J. Antibiotic treatment expands the resistance reservoir and ecological network of the phage metagenome. Nature 499, 219\u2013222 (2013).","journal-title":"Nature"},{"key":"61703_CR67","doi-asserted-by":"crossref","unstructured":"Munita, J. M. & Arias, C. A. Mechanisms of antibiotic resistance. Microbiol. Spectr. 4:10.1128 (2016).","DOI":"10.1128\/microbiolspec.VMBF-0016-2015"},{"key":"61703_CR68","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S0929-6646(08)60145-X","volume":"107","author":"WJ Su","year":"2008","unstructured":"Su, W. J., Feng, J. Y., Huang, C. C. & Perng, R. P. Increasing drug resistance of Mycobacterium tuberculosis isolates in a medical center in northern Taiwan. J. Formos. Med. Assoc. 107, 259\u2013264 (2008).","journal-title":"J. Formos. Med. Assoc."},{"key":"61703_CR69","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofad534","volume":"10","author":"JA Lindsey","year":"2023","unstructured":"Lindsey, J. A. et al. Rifampin mono-resistant tuberculosis in New York City, 2010-2021: a retrospective case series. Open Forum Infect. Dis. 10, ofad534 (2023).","journal-title":"Open Forum Infect. Dis."},{"key":"61703_CR70","doi-asserted-by":"publisher","first-page":"13881","DOI":"10.1073\/pnas.2235848100","volume":"100","author":"R Rawat","year":"2003","unstructured":"Rawat, R., Whitty, A. & Tonge, P. J. The isoniazid-NAD adduct is a slow, tight-binding inhibitor of InhA, the Mycobacterium tuberculosis enoyl reductase: adduct affinity and drug resistance. Proc. Natl. Acad. Sci. USA 100, 13881\u201313886 (2003).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"61703_CR71","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/ng.3195","volume":"47","author":"M Merker","year":"2015","unstructured":"Merker, M. et al. Evolutionary history and global spread of the Mycobacterium tuberculosis Beijing lineage. Nat. Genet. 47, 242\u2013249 (2015).","journal-title":"Nat. Genet."},{"key":"61703_CR72","doi-asserted-by":"publisher","first-page":"eabg2612","DOI":"10.1126\/scitranslmed.abg2612","volume":"13","author":"K Saito","year":"2021","unstructured":"Saito, K. et al. Oxidative damage and delayed replication allow viable Mycobacterium tuberculosis to go undetected. Sci. Transl. Med. 13, eabg2612 (2021).","journal-title":"Sci. Transl. Med."},{"key":"61703_CR73","doi-asserted-by":"publisher","first-page":"E4832","DOI":"10.1073\/pnas.1705385114","volume":"114","author":"K Saito","year":"2017","unstructured":"Saito, K. et al. Rifamycin action on RNA polymerase in antibiotic-tolerant Mycobacterium tuberculosis results in differentially detectable populations. Proc. Natl. Acad. Sci. USA 114, E4832\u2013E4840 (2017).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"61703_CR74","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.chom.2013.05.009","volume":"13","author":"NR Cohen","year":"2013","unstructured":"Cohen, N. R., Lobritz, M. A. & Collins, J. J. Microbial persistence and the road to drug resistance. Cell Host Microbe 13, 632\u2013642 (2013).","journal-title":"Cell Host Microbe"},{"key":"61703_CR75","doi-asserted-by":"publisher","first-page":"eaaz6992","DOI":"10.1126\/scitranslmed.aaz6992","volume":"12","author":"SM Schrader","year":"2020","unstructured":"Schrader, S. M., Vaubourgeix, J. & Nathan, C. Biology of antimicrobial resistance and approaches to combat it. Sci. Transl. Med.12, eaaz6992 (2020).","journal-title":"Sci. Transl. Med."},{"key":"61703_CR76","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.tube.2003.08.003","volume":"84","author":"JE Gomez","year":"2004","unstructured":"Gomez, J. E. & McKinney, J. D. M. tuberculosis persistence, latency, and drug tolerance. Tuberculosis 84, 29\u201344 (2004).","journal-title":"Tuberculosis"},{"key":"61703_CR77","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/nature10069","volume":"473","author":"KR Allison","year":"2011","unstructured":"Allison, K. R., Brynildsen, M. P. & Collins, J. J. Metabolite-enabled eradication of bacterial persisters by aminoglycosides. Nature 473, 216\u2013220 (2011).","journal-title":"Nature"},{"key":"61703_CR78","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.molcel.2013.04.002","volume":"50","author":"SM Amato","year":"2013","unstructured":"Amato, S. M., Orman, M. A. & Brynildsen, M. P. Metabolic control of persister formation in Escherichia coli. Mol. Cell 50, 475\u2013487 (2013).","journal-title":"Mol. Cell"},{"key":"61703_CR79","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1146\/annurev.micro.112408.134306","volume":"64","author":"K Lewis","year":"2010","unstructured":"Lewis, K. Persister cells. Annu. Rev. Microbiol. 64, 357\u2013372 (2010).","journal-title":"Annu. Rev. Microbiol."},{"key":"61703_CR80","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1099\/jmm.0.009720-0","volume":"58","author":"R Singh","year":"2009","unstructured":"Singh, R., Ray, P., Das, A. & Sharma, M. Role of persisters and small-colony variants in antibiotic resistance of planktonic and biofilm-associated Staphylococcus aureus: an in vitro study. J. Med. Microbiol. 58, 1067\u20131073 (2009).","journal-title":"J. Med. Microbiol."},{"key":"61703_CR81","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.3389\/fmicb.2020.01924","volume":"11","author":"F Boldrin","year":"2020","unstructured":"Boldrin, F., Provvedi, R., Cioetto Mazzabo, L., Segafreddo, G. & Manganelli, R. Tolerance and Persistence to Drugs: A Main Challenge in the Fight Against Mycobacterium tuberculosis. Front. Microbiol. 11, 1924 (2020).","journal-title":"Front. Microbiol."},{"key":"61703_CR82","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/nrmicro.2016.34","volume":"14","author":"A Brauner","year":"2016","unstructured":"Brauner, A., Fridman, O., Gefen, O. & Balaban, N. Q. Distinguishing between resistance, tolerance and persistence to antibiotic treatment. Nat. Rev. Microbiol. 14, 320\u2013330 (2016).","journal-title":"Nat. Rev. Microbiol."},{"key":"61703_CR83","doi-asserted-by":"publisher","first-page":"e02095","DOI":"10.1128\/mBio.02095-19","volume":"10","author":"EM Windels","year":"2019","unstructured":"Windels, E. M., Michiels, J. E., Van den Bergh, B., Fauvart, M. & Michiels, J. Antibiotics: Combatting Tolerance To Stop Resistance. MBio 10, e02095\u201319 (2019).","journal-title":"MBio"},{"key":"61703_CR84","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.cell.2007.06.049","volume":"130","author":"MA Kohanski","year":"2007","unstructured":"Kohanski, M. A., Dwyer, D. J., Hayete, B., Lawrence, C. A. & Collins, J. J. A common mechanism of cellular death induced by bactericidal antibiotics. Cell 130, 797\u2013810 (2007).","journal-title":"Cell"},{"key":"61703_CR85","doi-asserted-by":"publisher","first-page":"10276","DOI":"10.1074\/jbc.M110.200501","volume":"286","author":"T Yano","year":"2011","unstructured":"Yano, T. et al. Reduction of clofazimine by mycobacterial type 2 NADH:quinone oxidoreductase: a pathway for the generation of bactericidal levels of reactive oxygen species. J. Biol. Chem. 286, 10276\u201310287 (2011).","journal-title":"J. Biol. Chem."},{"key":"61703_CR86","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1038\/s41396-019-0344-9","volume":"13","author":"EM Windels","year":"2019","unstructured":"Windels, E. M. et al. Bacterial persistence promotes the evolution of antibiotic resistance by increasing survival and mutation rates. ISME J. 13, 1239\u20131251 (2019).","journal-title":"ISME J."},{"key":"61703_CR87","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.cell.2020.02.026","volume":"181","author":"CR Ruhl","year":"2020","unstructured":"Ruhl, C. R. et al. Mycobacterium tuberculosis sulfolipid-1 activates nociceptive neurons and induces cough. Cell 181, 293\u2013305.e211 (2020).","journal-title":"Cell"},{"key":"61703_CR88","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1080\/21505594.2020.1809326","volume":"11","author":"M Vanaporn","year":"2020","unstructured":"Vanaporn, M. & Titball, R. W. Trehalose and bacterial virulence. Virulence 11, 1192\u20131202 (2020).","journal-title":"Virulence"},{"key":"61703_CR89","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/nature12337","volume":"499","author":"JE Galagan","year":"2013","unstructured":"Galagan, J. E. et al. The Mycobacterium tuberculosis regulatory network and hypoxia. Nature 499, 178\u2013183 (2013).","journal-title":"Nature"},{"key":"61703_CR90","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1038\/s41564-019-0480-z","volume":"4","author":"VI Band","year":"2019","unstructured":"Band, V. I. et al. Antibiotic combinations that exploit heteroresistance to multiple drugs effectively control infection. Nat. Microbiol. 4, 1627\u20131635 (2019).","journal-title":"Nat. Microbiol."},{"key":"61703_CR91","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S0076-6879(05)09012-9","volume":"409","author":"PL Foster","year":"2006","unstructured":"Foster, P. L. Methods for determining spontaneous mutation rates. Methods Enzymol. 409, 195\u2013213 (2006).","journal-title":"Methods Enzymol."},{"key":"61703_CR92","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger, A. M., Lohse, M. & Usadel, B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30, 2114\u20132120 (2014).","journal-title":"Bioinformatics"},{"key":"61703_CR93","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1101\/gr.247064.118","volume":"29","author":"A Viehweger","year":"2019","unstructured":"Viehweger, A. et al. Direct RNA nanopore sequencing of full-length coronavirus genomes provides novel insights into structural variants and enables modification analysis. Genome Res. 29, 1545\u20131554 (2019).","journal-title":"Genome Res."},{"key":"61703_CR94","doi-asserted-by":"publisher","DOI":"10.1093\/gigascience\/giab008","volume":"10","author":"P Danecek","year":"2021","unstructured":"Danecek, P. et al. Twelve years of SAMtools and BCFtools. Gigascience 10, giab008 (2021).","journal-title":"Gigascience"},{"key":"61703_CR95","doi-asserted-by":"publisher","first-page":"80","DOI":"10.4161\/fly.19695","volume":"6","author":"P Cingolani","year":"2012","unstructured":"Cingolani, P. et al. A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3. Fly 6, 80\u201392 (2012).","journal-title":"Fly"},{"key":"61703_CR96","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-016-1745-2","volume":"16","author":"I Ullah","year":"2016","unstructured":"Ullah, I. et al. Rifampicin resistance mutations in the 81 bp RRDR of rpoB gene in Mycobacterium tuberculosis clinical isolates using Xpert MTB\/RIF in Khyber Pakhtunkhwa, Pakistan: a retrospective study. BMC Infect. Dis. 16, 413 (2016).","journal-title":"BMC Infect. Dis."},{"key":"61703_CR97","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/s42003-025-07639-2","volume":"8","author":"M Guha","year":"2025","unstructured":"Guha, M., Singh, A. & Butzin, N. C. Priestia megaterium cells are primed for surviving lethal doses of antibiotics and chemical stress. Commun. Biol. 8, 206 (2025).","journal-title":"Commun. Biol."},{"key":"61703_CR98","doi-asserted-by":"publisher","unstructured":"Cross, T. et al. Prevalence and mechanisms of high-level carbapenem antibiotic tolerance in clinical isolates of Klebsiella pneumonia. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2025.02.19.639047 (2025).","DOI":"10.1101\/2025.02.19.639047"},{"key":"61703_CR99","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1038\/s41564-020-0737-6","volume":"5","author":"B Luna","year":"2020","unstructured":"Luna, B. et al. A nutrient-limited screen unmasks rifabutin hyperactivity for extensively drug-resistant Acinetobacter baumannii. Nat. Microbiol. 5, 1134\u20131143 (2020).","journal-title":"Nat. Microbiol."},{"key":"61703_CR100","doi-asserted-by":"publisher","first-page":"3799","DOI":"10.1128\/AAC.00647-09","volume":"53","author":"N Banaei","year":"2009","unstructured":"Banaei, N. et al. Lipoprotein processing is essential for resistance of Mycobacterium tuberculosis to malachite green. Antimicrob. Agents Chemother. 53, 3799\u20133802 (2009).","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-61703-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-61703-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-61703-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T10:06:03Z","timestamp":1757239563000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-61703-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,11]]},"references-count":100,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["61703"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-61703-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4999164\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,11]]},"assertion":[{"value":"5 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6442"}}